USNA logo

USANA Health Sciences Inc. (USNA)

$13.55

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on USNA

Market cap

$250357036

EPS

-1.18

P/E ratio

--

Price to sales

0.27

Dividend yield

--

Beta

0.729517

Price on USNA

Previous close

$13.18

Today's open

$13.25

Day's range

$13.12 - $13.56

52 week range

$12.57 - $32.32

Profile about USNA

CEO

Kevin Guest

Employees

1700

Headquarters

Salt Lake City, UT

Exchange

New York Stock Exchange

Shares outstanding

18476534

Issue type

Common Stock

USNA industries and sectors

Consumer Staples

Consumer Products - Healthcare

News on USNA

USANA Introduces 3-in-1 Protein, Creatine, and Electrolyte Drink Mix

New Clear Protein + Creatine Mix combines three active nutrition essentialswith 10 g of protein, 5 g of creatine, and 600+ mg of electrolytes in just 50calories  SALT LAKE CITY, Aug. 17, 2026 /PRNewswire/ -- Many active adults use separate products for protein, creatine, and hydration—adding cost, complexity, and extra steps to their daily routines. To simplify that routine, USANA Health Sciences (NYSE: USNA) today announced the launch of Clear Protein + Creatine Mix, bringing all three—clear whey protein isolate, micronized creatine monohydrate, and electrolytes—into one refreshing, 50-calorie drink.

news source

PRNewsWire • Aug 17, 2026

news preview

Why Usana Health Sciences Stock Plummeted This Week

Usana's Q2 earnings came in way below expectations, and sales were also lower than expected. Usana now expects to record a loss for the full-year period.

news source

The Motley Fool • Aug 9, 2026

news preview

USANA Health Sciences Q2 Earnings Call Highlights

USANA Health Sciences NYSE: USNA said its core nutritional business remained in line with expectations during the second quarter of 2026, while near-term challenges at its Hiya and Rise Wellness ventures led the company to lower its full-year outlook.

news source

MarketBeat • Aug 9, 2026

news preview

USANA Health Sciences, Inc. (USNA) Q2 2026 Earnings Call Transcript

USANA Health Sciences, Inc. (USNA) Q2 2026 Earnings Call Transcript

news source

Seeking Alpha • Aug 5, 2026

news preview

USANA Chairman, CEO Kevin Guest Shares 5 Ways to Make Happiness Happen at Work and Home This August

SALT LAKE CITY, Aug. 5, 2026 /PRNewswire/ -- With August recognized as Happiness Happens Month, Kevin Guest, Chairman and CEO of USANA Health Sciences (NYSE: USNA), is encouraging people to intentionally notice, create, and share more moments of genuine happiness at work and in their personal lives. "Happiness isn't a prize you receive after everything goes perfectly," said Guest, author of All the Right Reasons: 12 Timeless Principles for Living a Life in Harmony.

news source

PRNewsWire • Aug 5, 2026

news preview

USANA Health Sciences: No Clear Growth Engine Left (Rating Downgrade)

USANA Health Sciences, Inc. stock fell sharply after Q2 earnings. The direct selling business has continued to shrink at quite a predictable pace. USNA's two growth brands, Hiya and Rise Wellness, showed a concerning performance. Revenues plummeted, and the brands' 2026 guidance was cut massively.

news source

Seeking Alpha • Aug 5, 2026

news preview

USANA Health Sciences Reports Second Quarter 2026 Results

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal second quarter ended July 4, 2026. Key Financial Results Second Quarter 2026 vs. Second Quarter 2025 Net sales of $223 million versus $236 million. Net loss of $(21.4) million, which includes an estimated preliminary non-cash impairment charge(3) of $29.1 million, versus net earnings of $9.7 million. Diluted EPS of $(1.16) as compared with $0.52. Adjusted diluted EPS(1) of.

news source

Business Wire • Aug 4, 2026

news preview

USANA Health Sciences (USNA) Reports Q2 Loss, Lags Revenue Estimates

USANA Health Sciences (USNA) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of $0.43. This compares to earnings of $0.74 per share a year ago.

news source

Zacks Investment Research • Aug 5, 2026

news preview

New 12-Week Consumer Study Highlights Visible Skin Benefits with USANA Glow

Consumer study reports improvements in brighter-looking, more radiant, andmore even-toned skin after 12 weeks SALT LAKE CITY, July 30, 2026 /PRNewswire/ -- USANA Health Sciences (NYSE: USNA), a global leader in cellular nutrition, today announced the results of a new 12-week consumer study evaluating Glow, USANA's skincare supplement designed to support healthy, radiant-looking skin from within.* The 12-week consumer trial included 36 participants across the United States (22) and Mexico (14).

news source

PRNewsWire • Jul 30, 2026

news preview

USANA Health Sciences Renews Four-Year Partnership with Nordiq Canada, Deepening Commitment to Clean Sport and Elite Athlete Nutrition

The renewed agreement extends USANA's role as the official nutrition partner of Nordiq Canada, supporting Canada's elite cross-country ski athletes through 2028 and beyond SALT LAKE CITY, July 20, 2026 /PRNewswire/ -- USANA Health Sciences, Inc. (NYSE: USNA), a global leader in science-based nutrition, today announced a renewal of its official partnership with Nordiq Canada, the national governing body for cross-country skiing in Canada. Under the renewed agreement, USANA will continue supplying Nordiq Canada's elite athletes with premium, NSF Certified for Sport® nutritional products designed to support performance, normal muscle recovery after exercise, and long-term health—through the 2030 Olympic Winter Games and beyond.

news source

PRNewsWire • Jul 20, 2026

news preview

¹ Disclosures

Get started with M1

Invest in USANA Health Sciences Inc.

Open an M1 investment account to buy and sell USANA Health Sciences Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in USNA on M1